Abstract: Although hundreds of heparan sulfate (HS) binding proteins have been implicated in a myriad of physiological and pathological processes, very little information is known about ligand requirements for binding and mediating biological activities by these proteins. We report here a streamlined approach for the preparation of modular disaccharide building blocks that will facilitate the assembly of libraries of HS oligosaccharides for structure-activity relationship studies. In particular, we have found that glucuronic acid donors, which usually perform poorly in glycosylations, can give high yields of coupling product when the C-2 hydroxyl is protected with a permanent 4-acetoxy-2,2-dimethyl butanoyl-(PivOAc) or temporary levulinoyl (Lev) ester and the C-4 hydroxyl modified with a selectively removable 2-methylnaphthyl (Nap) ether.
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Organic & Biomolecular Chemistry www.rsc.org/obc Although many heparan sulfate-binding proteins have been identified, the oligosaccharide structure that mediates a particular interaction has been defined in only a very few cases. [6] [7] [8] This problem is mainly due to the structural complexity of HS, which in turn, arises from a complex biosynthetic pathway. To address this difficulty, we have developed a modular approach for the chemical synthesis of HS oligosaccharides whereby a set of disaccharide building blocks, which resemble the different disaccharide motifs found in HS, can repeatedly be used for the assembly of a wide range of sulfated oligosaccharides ( Figure 1 ). [9] [10] [11] [12] [13] In this approach, levulinoyl esters (Lev) 14 are employed for the protection of hydroxyls that need sulfation. In HS, the C-3 and C-6 of glucosamine and C-2 hydroxyls of uronic acids can be sulfated and therefore depending on the sulfation pattern of a targeted disaccharide module, one or more of these positions are protected as Lev esters. In case the C-2 position of a disaccharide module does not need sulfation, an acetyl ester is employed as a permanent protecting group. An azido group is used as an aminomasking functionality because it does not perform neighboring group participation and therefore allows the introduction of α-glucosides. 15 The C-4' hydroxyl, which is required for extension, is protected as 9-fluorenylmethyl carbonate (Fmoc), and this protecting group can be removed using a hindered base such as Et 3 N without affecting the Lev ester. On the other hand, the Lev group can be cleaved with hydrazine buffered with acetic acid and these conditions do not affect the Fmoc carbonate. 14 The anomeric center of the modular disaccharide building blocks is protected with a TDS ether and this functionality can easily be removed by treatment with HF in pyridine to give a lactol, which in turn, can be converted into a leaving group for glycosylations with appropriate acceptors. Compared to conventional approaches, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] a modular synthetic strategy makes it possible to rapidly assemble libraries of HS oligosaccharides for structure activity relationship studies.
Although modular assembly of HS oligosaccharide is very attractive, [9] [10] [11] [12] [13] [26] [27] the preparation of the disaccharide building blocks is time consuming. In particular, glycosyl donors derived from uronic acid often perform poorly in glycosylations due to a low reactivity which is caused by the electron withdrawing carboxylic acid that destabilizes the oxacarbenium ion like transition state of glycosylations. [28] [29] [30] Therefore, it is common to employ a post-glycosylation oxidation approach in which an oligosaccharide is assembled followed by selective oxidation of the C-6
hydroxyl of glucosides or idosides to the corresponding carboxylic acid. Such an approach requires additional reaction steps of advanced intermediates reducing the overall efficiency of the process.
Here, we report a detailed examination of the influence of protecting group patterns of uronyl donors on glycosylation efficiencies that led to the identification of new modular disaccharide building blocks that can readily be prepared without a need for post-glycosylation oxidation.
Results and Discussion
It is well known that the nature of a C-2 ester of a glycosyl donor can have a profound influence on the outcome of glycosylations. In this respect, the use of pivaloyl esters at C-2 can suppress orthoester formation, however, the removal of this protecting group requires harsh conditions which may not be compatible with the presence of sulfate esters in large complex HS oligosaccharides. 31 The 4-acetoxy-2,2-dimethyl butanoyl (PivOAc) ester has the steric advantage of the pivaloyl group but can be removed under mild basic conditions by a relay mechanism.
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Thus, we set out to prepare glycosyl donors 14, 15 and 16 (Scheme 1) which carry at C-2 an acetyl-, Lev-or PivOAc ester, respectively, and examine their glycosyl donor properties in glycosylations with glycosyl acceptor 17 (Scheme 2). The glycosyl donors could readily be prepared starting from compound 1, which has a free hydroxyl at C-2. Acetylation of 1 under standard conditions provided 2, whereas treatment of the same compound with levulinic acid in the presence of N,N'-Dicyclohexylcarbodiimide (DDC) and 4-dimethylaminopyridine (DMAP) gave compound 6. PivOAc protected 4 could readily be prepared in a high yield by a reaction of 1 with 4-acetoxy-2,2-dimethyl butanoyl chloride in the presence of DMAP in pyridine. The benzylidene acetal of compounds 2-4 was removed to give diols 5-7, respectively and the primary hydroxyl of these compounds was selectively oxidized using 2,2,6,6-tetramethyl-1-piperidinyloxy (TEMPO) in the presence of iodobenzene diacetate (BAIB) as the cooxidant.
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The resulting carboxylic acids were protected as methyl esters using diazomethane to provide derivatives 8-10. The C-4 hydroxyl of the latter compounds was protected as a Fmoc carbonate by treatment with FmocCl in pyridine to give compounds 11-13 in yields ranging form 76-87%.
Removal of the anomeric TDS group of the fully protected compounds 11-13 with HF in pyridine and subsequent installation of an anomeric trichloroacetimidate 37 using trichloroacetonitrile and NaH in DCM provided the required glycosyl donors 14-16, respectively.
The latter reaction conditions did not affect the base labile Fmoc protecting group.
As expected, a triflic acid (TfOH) mediated glycosylation of trichloroacetimidate 14 with glycosyl acceptor 17 did not lead to the formation of disaccharide 18 and instead hydrolyzed donor and the corresponding trehalose were isolated (Scheme 2). A similar glycosylation with glycosyl donor 15, having a Lev ester at C-2, provided the corresponding disaccharide 19 as only the β-anomer in a low yield of 27%. The use of PivOAc protected glycosyl donor 16 improved the outcome of the glycosylation, however, the corresponding disaccharide 20 was isolated in a disappointing yield of 36%.
In addition to the C-2 functionality of a glycosyl donor, other protecing groups may affect the outcome of glycosylations. We reasoned that the electron withdrawing carbonate at C-4 further reduces the reactivity of the glucuronic acid donors, which have low intrinsic glycosyl donating properties. Thus, replacement of this protecting group by a C-4 ether was expected to increase the anomeric reactivity which may lead to higher yields of glycosylation products. To test this hypothesis, glycosyl donors 21, 23 and 25 were prepared (see SI) and examined in TfOH mediated glycosylations with glycosyl acceptor 17 (Scheme 3). Gratifyingly, the use of glycosyl donors 23 and 25 resulted in improved glycosylation outcomes and the disaccharides 24 and 26
were isolated as only the β-anomers in yields of 61% and 71%, respectively. The coupling with glycosyl donor 21 to give disaccharide 22 was still low yielding (22%) due to the formation of a substantial quantity of trehalose.
The modular synthesis of heparan sulfate requires disaccharides having a removable protecting group at C-4 of the glucuronic moiety. Therefore, we examined the use of glycosyl donor 27 that has a 2-methylnaphthyl (Nap) ether at C-4, which can be removed by oxidation with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ). As expected, coupling of 27 with glycosyl acceptor 28 provided disaccharide 29 in a yield of 88%. These results show that glucuronyl donors having an ether protecting group at C-4 and a Lev or PivOAc ester at C-2 perform well in glycosylations with 2-azido-2-deoxy glycosyl acceptors having a free C-4 hydroxyl.
Next, we examined whether a Lev ester can be selectively removed in the presence of a PivOAc ester to give an alcohol for selective sulfation. For this purpose, disaccharide 31 was prepared by a TfOH catalyzed glycosylation of glycosyl donor 27 with glycosyl acceptor 30 (Scheme 4). The latter disaccharide has a Lev ester at C-6 that allows the installation of a sulfate ester, and an anomeric N-(benzyl)benzyloxycarbonyl protected aminopentanol moiety, which after deprotection provides opportunities for conjugation chemistry. As designed, removal of the Lev ester of 31 by treatment with hydrazine acetate in a mixture of toluene and ethanol followed by sulfation of the resulting hydroxyl of 32 with pyridinium sulfur trioxide lead to the clean formation of monosulfate 33. Importantly, these conditions did not affect the PivOAc ester.
However, the latter protecting group and the acetyl and methyl esters of 33 could readily be saponified by a two-step procedure employing first LiOH in a mixture of hydrogen peroxide and THF and then sodium hydroxide in methanol to give partially deprotected 34. After quenching the reaction with MeOH (50 µL), the mixture was diluted with DCM (50 mL) and washed with saturated aqueous sodium bicarbonate (2 × 50 mL) and brine (50 mL). The organic phase was dried (MgSO 4 ), filtered, and the filtrate was concentrated in vacuo. The residue was purified by silica gel column chromatography using a gradient of hexanes and
EtOAc to yield Fmoc carbonate-protected monosaccharide.
General procedure for preparation of trichloroacetimidates. Monosaccharide was dissolved in THF (0.05 M) followed by the addition of HF·pyridine (100 equiv). After stirring for 18 h, the reaction mixture was diluted with DCM (50 mL) and washed with water (50 mL), saturated aqueous sodium bicarbonate (50 mL), and brine (50 mL). The organic phase was dried (MgSO 4 ) and filtered, and the filtrate was concentrated in vacuo. The residue was chromatographed over silica gel using a gradient of hexanes and EtOAc to give pure lactol. To a solution of the lactol in DCM (0.05 M) was added trichloroacetonitrile (5 eq.) and NaH (60%, 1 eq.). After stirring at room temperature for 1.5 h, the reaction mixture was concentrated in vacuo. The residue was chromatographed over silica gel using a mixture of hexanes and EtOAc containing 0.01% pyridine to yield a trichloroacetimidate donor, which was used directly for glycosylations. 
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